Home - Syndax

Determined to realize a future in which people with cancer live longer and better than ever before.

Clinical Trials

12.18.20

Syndax Pharmaceuticals To Be Added to the NASDAQ Biotechnology Index

12.11.20

Syndax Announces Closing of Public Offering and Exercise in Full of the Underwriters' Option to Purchase Additional Shares

12.09.20

Syndax Announces Pricing of Public Offering of Common Stock

12.07.20

Syndax Announces Proposed Public Offering of Common Stock